Aytu BioPharma, Inc. (AYTU) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -4.18M | 3.67M | -618K | 2.8M | -6.46M | 2.9M | -1.19M | -788K | -254K | -135K | -211K | 9.37M | -2.91M | -2.44M | -9.15M | -7.09M | -9.12M | -8.82M | -3.79M | -6.29M |
| Operating CF Margin % | -33.7% | 24.23% | -4.45% | 18.52% | -34.98% | 17.91% | -7.18% | -4.38% | -1.81% | -0.72% | -1.18% | 30.47% | -12.78% | -9.29% | -33.08% | -25.85% | -37.67% | -38.15% | -17.31% | -26.77% |
| Operating CF Growth % | 35.21% | 26.51% | 48.07% | 455.71% | -2441.34% | 2251.85% | -463.98% | -108.41% | 91.26% | 94.47% | 97.69% | 231.99% | 68.12% | 72.34% | -141.31% | -12.87% | -3.84% | -201.71% | 52.51% | 19.04% |
| Net Income | -5.62M | -10.58M | 1.97M | -19.88M | 3.99M | 788K | 1.47M | -4.62M | -2.89M | -220K | -8.12M | -2.46M | -7.2M | -6.69M | -701K | -16.09M | -53.07M | -11.55M | -27.85M | -19M |
| Depreciation & Amortization | 1.12M | 885K | 803K | 1.29M | 1.48M | 1.17M | 1.43M | 1.69M | 1.53M | 1.79M | 1.84M | 2.12M | 2.19M | 2.21M | 2.3M | 2.22M | 2.65M | 2.67M | 2.68M | 2.83M |
| Stock-Based Compensation | 0 | 283K | 114K | 0 | 139K | 151K | 173K | 242K | 699K | 707K | 725K | 900K | 902K | 3.07M | 1.18M | 1.23M | 0 | 1.23M | 1.52M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.13M | 9.11M | -3.48M | 19.75M | -2.31M | -2.44M | -3.41M | 3.47M | -16K | 1.27M | 6.69M | 6.35M | -3.09M | 1.44M | -1.84M | 12.17M | 44.81M | 183K | 19.65M | 4.78M |
| Working Capital Changes | -1.81M | 3.98M | -23K | 1.64M | -9.76M | 3.24M | -854K | -1.57M | 417K | -3.68M | -1.35M | 2.46M | 4.29M | -2.46M | -10.08M | -6.63M | -3.5M | -1.36M | 211K | 5.1M |
| Change in Receivables | 6.43M | 2.3M | -2.07M | 4.67M | -10.51M | -2.27M | 478K | 5.73M | 1.03M | 118K | -1.68M | 5.18M | -8.5M | 2.38M | -6.21M | 5.89M | -4.54M | -1.34M | 6.53M | -228.27K |
| Change in Inventory | 543K | 609K | 1.06M | -518K | -61K | 627K | 334K | -2.01M | -1.01M | -684K | -1.12M | -622K | -804K | -79K | -2.1M | 1.21M | 659K | -390K | -178K | 7.18M |
| Change in Payables | -1.04M | -1.08M | 1.74M | -1.44M | 398K | -1.81M | 3.14M | 0 | 852K | -4.01M | 946K | -1.34M | 4.56M | -4.42M | 3.59M | 0 | -4.79M | 6.58M | -9.89M | 2.91M |
| Cash from Investing | 0 | -17K | 0 | -3.02M | -69K | 145K | 381K | -34K | -45K | -174K | -76K | -155K | 1K | -5K | 42K | -41K | -70K | -3.05M | -86K | -2.42M |
| Capital Expenditures | 0 | -17K | 0 | -3.02M | -69K | -6K | -136K | -329K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | 0.11% | - | 19.93% | 0.37% | 0.04% | 0.82% | 1.83% | - | - | - | - | - | - | - | - | - | - | - | 0% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 5K | -5K | 0 | -40K | 0 | 0 | 0 | -121.07K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 151K | 517K | 295K | -45K | -174K | -76K | -150K | -4K | 0 | 42K | -1K | -70K | -3.05M | -86K | -2.3M |
| Cash from Financing | 872K | -6.26M | 2.3M | 12.99M | 4.3M | -2.76M | 911K | 1.07M | 530K | -126K | -2.73M | -5.4M | 2.58M | -1.86M | 13.56M | -1.12M | 1.52M | 6.59M | -5.46M | 11.82M |
| Debt Issued (Net) | 872K | -6.26M | 2.3M | -1.85M | 5.55M | -723K | 1.41M | -15.65M | 530K | -212K | -370K | -8.86M | 2.9M | -632K | 4.25M | -26K | -5.74M | 2.22M | -5.74M | -508.44K |
| Equity Issued (Net) | 0 | 0 | 0 | 14.84M | 0 | 0 | 0 | 0 | 0 | 86K | 0 | 2.56M | 1.44M | 1.16M | 10.42M | -1.01M | 7.26M | 4.37M | 286K | 12.33M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.01M | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -1.25M | -2.04M | -500K | 16.72M | 0 | 0 | -2.36M | 896K | -1.76M | -2.39M | -1.11M | -85K | -1K | 0 | -6K | -5K |
| Net Change in Cash | -3.31M | -2.6M | 1.68M | 12.78M | -2.23M | 290K | 102K | 246K | 231K | -435K | -3.02M | 3.81M | -322K | -4.31M | 4.45M | -8.25M | -7.66M | -5.28M | -9.34M | 3.11M |
| Free Cash Flow | -4.18M | 3.66M | -618K | 2.79M | -6.52M | 2.9M | -1.33M | -1.12M | -254K | -135K | -211K | 9.37M | -2.91M | -2.44M | -9.15M | -7.09M | -9.12M | -8.82M | -3.79M | -6.29M |
| FCF Margin % | -33.7% | 24.12% | -4.45% | 18.41% | -35.36% | 17.87% | -8% | -6.21% | -1.81% | -0.72% | -1.18% | 30.47% | -12.78% | -9.29% | -33.08% | -25.85% | -37.67% | -38.15% | -17.31% | -26.77% |
| FCF Growth % | 35.9% | 26.18% | 53.39% | 349.42% | -2468.5% | 2247.41% | -528.44% | -111.93% | 91.26% | 94.47% | 97.69% | 231.99% | 68.12% | 72.34% | -141.31% | -12.87% | -3.84% | -201.71% | 52.51% | 19.04% |
| FCF per Share | -0.40 | 0.36 | -0.03 | 0.41 | -0.80 | 0.34 | -0.15 | -0.20 | -0.05 | -0.02 | -0.04 | 2.31 | -0.78 | -0.78 | -3.63 | -3.94 | -6.16 | -6.68 | -2.87 | -5.33 |
| FCF Conversion (FCF/Net Income) | 0.74x | -0.35x | -0.31x | -0.14x | -1.62x | 3.69x | -0.81x | 0.17x | 0.09x | 0.61x | 0.03x | -3.81x | 0.40x | 0.36x | 13.05x | 0.44x | 0.17x | 0.76x | 0.14x | 0.33x |
| Interest Paid | 0 | 0 | 466K | 0 | 1.17M | 386K | 366K | 875K | 994K | 811K | 1.36M | 951K | 840K | 1.46M | 565K | 68K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 140K | 0 | 0 | 973K | 446K | 0 | 130K | 186K | 246K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |